X

ULTRAFEN 50 SUPPOSITORY 50mg

Product Information

Registration Status: Active

SIN10519P

ULTRAFEN 50 SUPPOSITORY 50mg is approved to be sold in Singapore with effective from 1998-08-12. It is marketed by PHARMATECH RESOURCES (FE) PTE LTD, with the registration number of SIN10519P.

This product contains Diclofenac 50mg in the form of SUPPOSITORY. It is approved for RECTAL use.

This product is manufactured by BEXIMCO PHARMACEUTICALS LTD in BANGLADESH.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Product Reference
Loading...


Description

A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. [PubChem]

Indication

For the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.

Mechanism of Action

The antiinflammatory effects of diclofenac are believed to be due to inhibition of both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis is responsible for the analgesic effects of diclofenac. Antipyretic effects may be due to action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat dissipation.

Pharmacokinetics

Absorption
Completely absorbed from the gastrointestinal tract.
Distribution
* 1.3 L/kg
Metabolism
Hepatic
Elimination

Clearance

* oral cl=622 mL/min [healthy] * renal cl

Toxicity

Symptoms of overdose include loss of consciousness, increased intracranial pressure, and aspiration pneumonitis. LD50=390mg/kg (orally in mice)

Active Ingredient/Synonyms

[2-(2,6-dichloroanilino)phenyl]acetic acid | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid | Diclofenac Acid | Diclofenaco | Diclofenacum | Diclofenac |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank

Pharmfair.com uses cookies to improve your browsing experience. We'll assume you're ok with this, but you can opt-out if you wish. Peace!